Asia Pacific Precision Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Type (Genetic Tests, Direct to Consumer Tests, Esoteric Tests, and Others), By Application (Oncology, Respiratory Diseases, Skin Diseases, CNS Disorders, and Others), By End-Use (Hospitals, Clinical Laboratories, and Others), and Asia Pacific Precision Diagnostics Market Insights, Industry Trend, Forecasts to 2035.

Asia Pacific Precision Diagnostics Market Insights Forecasts To 2035

• The Asia Pacific Precision Diagnostics Market Size was Estimated at USD 778.19 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 12.28% from 2025 to 2035
• The Asia Pacific Precision Diagnostics Market Size is Expected to Reach USD 2478.98 Million by 2035

According to a research report published by Spherical Insights & Consulting, The Asia Pacific Precision Diagnostics Market Size is Anticipated To Reach USD 2478.98 Million by 2035, Growing at a CAGR of 12.28% from 2025 to 2035. The upsurging growth of personalized medicine, along with an increasing need for accurate and tailored diagnostics & treatment planning, is the key growth driver of the precision diagnostics market in the Asia Pacific region.

Market Overview

The Asia Pacific precision diagnostics market is the industry encompassing products, technologies, and services used for disease detection and diagnosis with high accuracy. Precision diagnostics is the branch of precision medicine that involves the analysis of an individual’s unique genetic, molecular, and other personal characteristics. Integration of artificial intelligence, especially convolutional neural networks and data analysis, aids in predicting the relationship between genotype and phenotype, potentially enhancing the sensitivity and specificity of precision diagnoses. The growing healthcare spending in infrastructure development, technological advancement, and research & development is providing lucrative growth opportunities in the precision diagnostics market.

Report Coverage

This research report categorizes the market for the Asia Pacific precision diagnostics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific precision diagnostics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific precision diagnostics market.

Driving Factors

Personalized diagnostics aid in delivering greater accuracy in disease identification, for earlier intervention and better clinical outcomes, thereby driving the precision diagnostics market. Advancements in sequencing technologies and their integration, along with the growing prevalence of chronic diseases, aid in propelling the market. Emergence of biobanks in precision medicine for providing well-characterized biological samples and related data for disease prediction, prevention, treatment, and management, contributing to promoting market growth.

Restraining Factors

The increased initial investment and complexity in data management and integration are challenging the precision diagnostics market. Further, the lack of awareness and strict regulations related to the development of new test kits are hampering the market growth.

Market Segmentation

The Asia Pacific precision diagnostics market share is classified into type, application, and end-use.

• The genetic tests segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific precision diagnostics market is segmented by type into genetic tests, direct to consumer tests, esoteric tests, and others. Among these, the genetic tests segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. It includes the molecular insights from individual genomes by using technologies like NGS to understand patients’ unique genetic makeup for diagnostics, promoting better healthcare.

• The oncology segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific precision diagnostics market is segmented by application into oncology, respiratory diseases, skin diseases, CNS disorders, and others. Among these, the oncology segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. Personalized and accurate diagnostic methods aid in identifying specific cancer types and their genetic makeup, facilitating targeted treatment approaches in oncology.

• The clinical laboratories segment dominated the market with the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The Asia Pacific precision diagnostics market is segmented by end-use into hospitals, clinical laboratories, and others. Among these, the clinical laboratories segment dominated the market with the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Advanced diagnostic technologies are extensively used in clinical laboratories for accurate disease detection and monitoring.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific precision diagnostics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott
• Bayer AG
• Koninklijke Philips N.V.
• Novartis AG
• QIAGEN
• Quest Diagnostics Incorporated
• Sanofi
• Siemens Healthineers AG
• Swiss Precision Diagnostics GmbH
• Others

Recent Developments:

• In June 2025, QIAGEN N.V. and Incyte announced a global collaboration to develop a novel diagnostic panel to support Incyte’s extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Precision Diagnostics Market based on the below-mentioned segments:

Asia Pacific Precision Diagnostics Market, By Type

• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

Asia Pacific Precision Diagnostics Market, By Application

• Oncology
• Respiratory Diseases
• Skin Diseases
• CNS Disorders
• Others

Asia Pacific Precision Diagnostics Market, By End-Use

• Hospitals
• Clinical Laboratories
• Others